Advertisement

Journal of Genetic Counseling

, Volume 24, Issue 3, pp 482–490 | Cite as

Storage and use of Newborn Screening Blood Specimens for Research: Assessing Public Opinion in Illinois

  • Alexa HartEmail author
  • Michael Petros
  • Joel Charrow
  • Claudia Nash
  • Catherine Wicklund
Original Research

Abstract

Storage and use of residual dried blood spots (DBS) from newborn screening (NBS) for research purposes has been a topic of elevated interest following high profile disputes between genetic privacy advocacy groups and state NBS programs. Our objective was to assess public opinion in Illinois regarding storage and use of residual DBS for research. Five hundred twenty-six Illinois residents completed a survey assessing attitudes about research uses for DBS, storage length, and consent issues. Over 80 % of respondents expressed agreement with questions regarding research uses of DBS. Eighty-three percent of respondents were in favor of storage for at least one year with 44 % favoring indefinite storage. Respondents with higher educational attainment were more likely to support research use of DBS and less likely to desire contact for each future study (P < 0.05). Black respondents were less likely than white respondents to express agreement for the use of DBS for research or to favor long-term storage (P < 0.05). Support was high for storage and use of DBS in our sample. Consent was important and respondents wanted choices about participation. Forty-two percent of respondents were not aware of NBS prior to this survey, highlighting a need for greater education about this public health program. Trust in the public health service of NBS must be protected through transparency in the policy process.

Keywords

Newborn screening Residual dried blood spots Public health policy Research Informed consent 

Notes

Acknowledgments

The authors gratefully acknowledge the following clinics for their assistance in conducting this study: Northwestern Memorial Faculty Foundation Obstetrics and Gynecology, East Side Health District, Jackson County Health Department, Jefferson County Health Department, Marion County Health Department, McLean County Health Department, Montgomery County Health Department, Rock Island County Health Department, and Southern Seven Health Department. The authors gratefully acknowledge the following Pediatric Practice Research Group practices for their participation in this study: North Suburban Pediatrics in Evanston, IL, Pediatric Specialists of the Northwest in Crystal Lake, IL, and Streeterville Pediatrics in Chicago, IL. We thank Dr. Barbara Bayldon, Dr. Helen Binns, and Dr. Adolfo Ariza for their thoughtful review and comments during survey development.

Conflict of Interest

Authors Alexa Hart, Michael Petros, Joel Charrow, Claudia Nash, and Catherine Wicklund each declare that they have no conflict of interest.

Informed Consent Statement

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 (5). Informed consent was obtained from all patients for being included in the study.

Animal Studies

No animal studies were carried out by the authors for this article.

References

  1. American College of Medical Genetics and Genomics. (2009). “Position Statement on Importance of Residual Newborn Screening Dried Blood Spots.” [accessed 04/17/2011].Google Scholar
  2. Bates, B. R., Lynch, J. A., Bevan, J. L., & Condit, C. M. (2005). Warranted concerns, warranted outlooks: a focus group study of public understandings of genetic research. Social Science and Medicine, 60(2), 331–44.CrossRefGoogle Scholar
  3. Benkendorf, J., Goodspeed, T., & Watson, M. S. (2010). Newborn screening residual dried blood spot Use for newborn screening quality improvement. Genetics in Medicine, 12(12), S269–72.CrossRefGoogle Scholar
  4. Blout, C., Walsh Vockley, C., Gaviglio, A., Fox, M., Croke, L., Williamson Dean, L., (2013) The Newborn Screening Task Force on behalf of the NSGC Public Policy Committee. "Newborn Screening: Education, Consent, and the Residual Blood Spot. The Position of the National Society of Genetic Counselors. Journal Genetics Counsil 23(1):16–9.Google Scholar
  5. Bombard, Y., Miller, F. A., Hayeems, R. Z., Carroll, J. C., Avard, D., Wilson, B. J., Little, J., Bytautas, J. P., Allanson, J., Axler, R., Giguere, Y., & Chakraborty, P. (2012). Citizens’ values regarding research with stored samples from newborn screening in Canada. Pediatrics, 129(2), 239–47.CrossRefGoogle Scholar
  6. Botkin, J. R., Rothwell, E., Anderson, R., Stark, L., Goldenberg, A., Lewis, M., Burbank, M., & Wong, B. (2012). Public attitudes regarding the Use of residual newborn screening specimens for research. Pediatrics, 129(2), 231–8.CrossRefGoogle Scholar
  7. Bussey-Jones, J., Garrett, J., Henderson, G., Moloney, M., Blumenthal, C., & Corbie-Smith, G. (2010). The role of race and trust in tissue/blood donation for genetic research. Genetics in Medicine, 12(2), 116–21.CrossRefGoogle Scholar
  8. Campbell, E., & Ross, L. F. (2003). Parental attitudes regarding newborn screening of Pku and Dmd. American Journal of Medical Genetics Part A, 120A(2), 209–14.CrossRefGoogle Scholar
  9. Cohen, E. (2010). “The Government Has Your Baby’s DNA.” CNN [accessed 04/17/2011].Google Scholar
  10. Couzin-Frankel, J. (2009). Newborn blood collections. Science gold mine, ethical minefield. Science, 324(5924), 166–8.CrossRefGoogle Scholar
  11. Duquette, D., A. P. Rafferty, C. Fussman, J. Gehring, S. Meyer, and J. Bach. (2010). “Public Support for the Use of Newborn Screening Dried Blood Spots in Health Research.” Public Health Genomics.Google Scholar
  12. Furr, L. A. (2002). Perceptions of genetics research as harmful to society: differences among samples of African-americans and european-americans. Genetic Testing, 6(1), 25–30.CrossRefGoogle Scholar
  13. Gallup, Inc., (2014). “Illinois Residents Least Trusting of Their State Government” http://www.gallup.com/poll/168251/illinois-residents-least-trusting-state-government.aspx - 2 (accessed 07/08/2014).
  14. Gallup, Inc., (2012). “Gallup State of the States” http://www.gallup.com/poll/125066/State-States.aspx (accessed 02/24/2012).
  15. Goldenberg, A. J., Hull, S. C., Botkin, J. R., & Wilfond, B. S. (2009). Pediatric biobanks: approaching informed consent for continuing research after children grow Up. Journal of Pediatrics, 155(4), 578–83.CrossRefGoogle Scholar
  16. Hendrix, K.S., Meslin, E.M., Carroll, A.E., Downs, S.M. (2013). Attitudes about the use of newborn dried blood spots for research: a survey of underrepresented parents. Academics Pediatrics, 13(5):451–7.CrossRefGoogle Scholar
  17. Kharaboyan, L., Avard, D., & Knoppers, B. M. (2004). Storing newborn blood spots: modern controversies. The Journal of Law, Medicine & Ethics, 32(4), 741–8.CrossRefGoogle Scholar
  18. Lemke, A. A., Wolf, W. A., Hebert-Beirne, J., & Smith, M. E. (2010). Public and biobank participant attitudes toward genetic research participation and data sharing. Public Health Genomics, 13(6), 368–77.CrossRefGoogle Scholar
  19. Lewis, M. H., Goldenberg, A., Anderson, R., Rothwell, E., & Botkin, J. (2011). State laws regarding the retention and Use of residual newborn screening blood samples. Pediatrics, 127(4), 703–12.CrossRefGoogle Scholar
  20. McEwen, J. E., & Reilly, P. R. (1994). Stored Guthrie cards as DNA “banks”. American Journal of Human Genetics, 55(1), 196–200.PubMedPubMedCentralGoogle Scholar
  21. Olney, R. S., Moore, C. A., Ojodu, J. A., Lindegren, M. L., & Hannon, W. H. (2006). Storage and Use of residual dried blood spots from state newborn screening programs. Journal of Pediatrics, 148(5), 618–22.CrossRefGoogle Scholar
  22. Pelias, M. K., & Markward, N. J. (2001). Newborn screening, informed consent, and future Use of archived tissue samples. Genetic Testing, 5(3), 179–85.CrossRefGoogle Scholar
  23. Pew Research Center. (2010). “Distrust, Discontent, Anger and Partisan Rancor: The People and Their Government”. http://pewresearch.org/pubs/1569/trust-in-government-distrust-discontent-anger-partisan-rancor [accessed 02/10/2012].
  24. Ramshaw, E. (2010). “DNA Deception.” The Texas Tribune, 02/22/2010.Google Scholar
  25. Tarini, B. A. (2011). Storage and Use of residual newborn screening blood spots: a public policy emergency. Genetics in Medicine, 13(7), 619–20.CrossRefGoogle Scholar
  26. Tarini, B. A., Goldenberg, A., Singer, D., Clark, S. J., Butchart, A., & Davis, M. M. (2010). Not without My permission: Parents’ willingness to permit Use of newborn screening samples for research. Public Health Genomics, 13(3), 125–30.CrossRefGoogle Scholar
  27. Therrell, B. L., Hannon, W. H., Pass, K. A., Lorey, F., Brokopp, C., Eckman, J., Glass, M., Heidenreich, R., Kinney, S., Kling, S., Landenburger, G., Meaney, F. J., McCabe, E. R., Panny, S., Schwartz, M., & Shapira, E. (1996). Guidelines for the retention, storage, and Use of residual dried blood spot samples after newborn screening analysis: statement of the council of regional networks for genetic services. Biochemical and Molecular Medicine, 57(2), 116–24.CrossRefGoogle Scholar
  28. Therrell, B. L., Johnson, A., & Williams, D. (2006). Status of newborn screening programs in the united states. Pediatrics, 117(5 Pt 2), S212–52.CrossRefGoogle Scholar
  29. Therrell, B. L., Jr., Hannon, W. H., Bailey, D. B., Jr., Goldman, E. B., Monaco, J., Norgaard-Pedersen, B., Terry, S. F., Johnson, A., & Howell, R. R. (2011). Committee report: considerations and recommendations for national guidance regarding the retention and Use of residual dried blood spot specimens after newborn screening. Genetics in Medicine, 13(7), 621–4.CrossRefGoogle Scholar
  30. Thiel, D.B., Platt, T., Platt, J., King, S.B., Kardia, S.L., (2013). Community Perspectives on Public Health Biobanking: an Analysis of Community Meetings on the Michigan BioTrust for Health. Journal Community Genetics 5(2):125–38CrossRefGoogle Scholar
  31. Tluczek, A., Orland, K. M., Nick, S. W., & Brown, R. L. (2009). Newborn screening: an appeal for improved parent education. The Journal of Perinatal & Neonatal Nursing, 23(4), 326–34.CrossRefGoogle Scholar
  32. Vladutiu, G. D. (2010). Considerations and recommendations for national guidance regarding the retention and Use of residual dried blood spots specimens after newborn screening. Molecular Genetics and Metabolism, 101(2–3), 93–4.CrossRefGoogle Scholar
  33. Waldo, A. (2010). “The Texas Newborn Bloodspot Saga Has Reached a Sad—and Prevent- Able—Conclusion.” Genomics Law Report. http://www.genomicslawreport.com/index.php/2010/03/16/the-texas-newborn-bloodspot-saga-has-reached-a-sad-and-preventable-conclusion/ [accessed 02/12/2012].

Copyright information

© National Society of Genetic Counselors, Inc. 2014

Authors and Affiliations

  • Alexa Hart
    • 1
    Email author
  • Michael Petros
    • 2
  • Joel Charrow
    • 3
  • Claudia Nash
    • 4
  • Catherine Wicklund
    • 5
  1. 1.Fetal and Neonatal Medicine CenterRush University Medical CenterChicagoUSA
  2. 2.School of Public HealthUniversity of Illinois at ChicagoChicagoUSA
  3. 3.Division of Genetics, Birth Defects and MetabolismAnn and Robert H. Lurie Children’s HospitalChicagoUSA
  4. 4.Illinois Department of Public HealthSpringfieldUSA
  5. 5.Center for Genetic Medicine, Feinberg School of MedicineNorthwestern UniversityChicagoUSA

Personalised recommendations